Olga Legina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Olga Legina has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Elena Zorina
Institute of Biomedical Chemistry, Pogodinskaya, 10, Moscow 119121, Russia
6 shared publications - Stanislav N. Naryzhny
Petersburg Nuclear Physics Institute named by B. P. Konstantinov of National Research Centre “Kurchatov Institute”, Gatchina 188300, Russia
6 shared publications - Nikolay Klopov
Petersburg Nuclear Physics Institute named by B. P. Konstantinov of National Research Centre “Kurchatov Institute”, Gatchina 188300, Russia
5 shared publications - Natalia Ronzhina
Petersburg Nuclear Physics Institute named by B. P. Konstantinov of National Research Centre “Kurchatov Institute”, Gatchina 188300, Russia
4 shared publications - Victor G. Zgoda
Institute of Biomedical Chemistry, Moscow 119121, Russia
4 shared publications - Natalia Ronzhina
Petersburg Nuclear Physics Institute named by B. P. Konstantinov of National Research Centre “Kurchatov Institute”, Gatchina 188300, Russia
2 shared publications
Latest Publications
- Open Access
The “2DE-Pattern” Database for Inventory of Proteoform Profiles: 2026 Upgrade and Update on Outcomes
Background: Modern proteomics faces a critical bottleneck: the vast discrepancy between the number of genes in the human genome and the exponentially greater variety of functional proteoforms that actually drive biological processes. Methods: Our paper addresses the urgent need for high-resolution systematic mapping of these proteoforms, arguing that the true frontier of molecular biology lies in the precise identification and categorization of protein variants. It centers on the development and expansion of the “2DE-pattern” database, a specialized platform designed to bridge the gap between theoretical protein sequences and the physical reality of proteins as captured through two-dimensional electrophoresis (2DE). The “2DE-pattern” database is based on information obtained by separation of proteoforms using 2DE followed by shotgun ESI LC-MS/MS. It was launched in 2020, contains multiple isoform-centric patterns of proteoforms, and can be freely used. Results: Here, we report the additional data and all updates that were added into this database. Also, the database was upgraded to be more research-oriented. Tools were incorporated into the database to allow convenient comparative analysis of the data. Conclusions: New additions and enhancements now allow us to consider our database a knowledge base.
Open AccessThe “2DE-Pattern” Database for Inventory of Proteoform Profiles: 2026 Upgrade and Update on Outcomes
Background: Modern proteomics faces a critical bottleneck: the vast discrepancy between the number of genes in the human genome and the exponentially greater variety of functional proteoforms that actually drive biological processes. Methods: Our paper addresses the urgent need for high-resolution systematic mapping of these proteoforms, arguing that the true frontier of molecular biology lies in the precise identification and categorization of protein variants. It centers on the development and expansion of the “2DE-pattern” database, a specialized platform designed to bridge the gap between theoretical protein sequences and the physical reality of proteins as captured through two-dimensional electrophoresis (2DE). The “2DE-pattern” database is based on information obtained by separation of proteoforms using 2DE followed by shotgun ESI LC-MS/MS. It was launched in 2020, contains multiple isoform-centric patterns of proteoforms, and can be freely used. Results: Here, we report the additional data and all updates that were added into this database. Also, the database was upgraded to be more research-oriented. Tools were incorporated into the database to allow convenient comparative analysis of the data. Conclusions: New additions and enhancements now allow us to consider our database a knowledge base.
- Open Access
- 22 June 2026
- Published by MDPI AG in Preprints.org
A Database “2DE-Pattern” for Inventory of Proteoform Profiles: 2026 Upgrade and Update on Outcomes
Modern proteomics faces a critical bottleneck: the vast discrepancy between the number of genes in the human genome and the exponentially greater variety of functional proteoforms that actually drive biological processes. Our paper addresses the urgent need for high-resolution systematic mapping of these proteoforms, arguing that the true frontier of molecular biology lies in the precise identification and categorization of protein variants. It centers on the development and expansion of the "2DE-pattern" database, a specialized platform designed to bridge the gap between theoretical protein sequences and the physical reality of protein expression as captured through two-dimensional electrophoresis (2DE). A database “2DE-pattern”is based on information obtained by separation of proteoforms using 2DE with following shot-gun ESI LC-MS/MS. It was launched in 2020, contains multiple isoform-centric patterns of proteoforms, and can be freely used at http://2de-pattern.pnpi.nrcki.ru. Here, we report the additional data and all updates that were added into this database. Also, it was upgraded to be more research-oriented. Some tools were incorporated into the database to allow the convenient comparative analysis of the data. Accordingly, it became now more like a knowledge database.
- 22 June 2026
- Published by MDPI AG in Preprints.org
Open AccessA Database “2DE-Pattern” for Inventory of Proteoform Profiles: 2026 Upgrade and Update on Outcomes
Modern proteomics faces a critical bottleneck: the vast discrepancy between the number of genes in the human genome and the exponentially greater variety of functional proteoforms that actually drive biological processes. Our paper addresses the urgent need for high-resolution systematic mapping of these proteoforms, arguing that the true frontier of molecular biology lies in the precise identification and categorization of protein variants. It centers on the development and expansion of the "2DE-pattern" database, a specialized platform designed to bridge the gap between theoretical protein sequences and the physical reality of protein expression as captured through two-dimensional electrophoresis (2DE). A database “2DE-pattern”is based on information obtained by separation of proteoforms using 2DE with following shot-gun ESI LC-MS/MS. It was launched in 2020, contains multiple isoform-centric patterns of proteoforms, and can be freely used at http://2de-pattern.pnpi.nrcki.ru. Here, we report the additional data and all updates that were added into this database. Also, it was upgraded to be more research-oriented. Some tools were incorporated into the database to allow the convenient comparative analysis of the data. Accordingly, it became now more like a knowledge database.
- Open Access
Proteoform Patterns in Hepatocellular Carcinoma Tissues: Aspects of Oncomarkers
Background: Human proteins exist in numerous modifications—proteoforms—which are promising targets for biomarker studies. In this study, we aimed to generate comparative proteomics data, including proteoform patterns, from hepatocellular carcinoma (HCC) and nonmalignant liver tissues. Methods: To investigate protein profiles and proteoform patterns, we employed a panoramic, integrative top-down proteomics approach: two-dimensional gel electrophoresis (2DE) coupled with liquid chromatography–electrospray ionization–tandem mass spectrometry (LC-ESI-MS/MS). Results: We visualized over 2500 proteoform patterns per sample type, enabling the identification of distinct protein signatures and common patterns differentiating nonmalignant and malignant liver cells. Among these, 1270 protein patterns were uniformly observed across all samples. Additionally, 38 proteins—including pyruvate kinase PKM (KPYM), annexin A2 (ANXA2), and others—exhibited pronounced differences in proteoform patterns between nonmalignant and malignant tissues. Conclusions: Most proteoform patterns of the same protein were highly similar, with the dominant peak corresponding to theoretical (unmodified) protein parameters. However, certain proteins displayed altered proteoform patterns and additional proteoforms in cancer compared to controls. These proteins were prioritized for further characterization.
Open AccessProteoform Patterns in Hepatocellular Carcinoma Tissues: Aspects of Oncomarkers
Background: Human proteins exist in numerous modifications—proteoforms—which are promising targets for biomarker studies. In this study, we aimed to generate comparative proteomics data, including proteoform patterns, from hepatocellular carcinoma (HCC) and nonmalignant liver tissues. Methods: To investigate protein profiles and proteoform patterns, we employed a panoramic, integrative top-down proteomics approach: two-dimensional gel electrophoresis (2DE) coupled with liquid chromatography–electrospray ionization–tandem mass spectrometry (LC-ESI-MS/MS). Results: We visualized over 2500 proteoform patterns per sample type, enabling the identification of distinct protein signatures and common patterns differentiating nonmalignant and malignant liver cells. Among these, 1270 protein patterns were uniformly observed across all samples. Additionally, 38 proteins—including pyruvate kinase PKM (KPYM), annexin A2 (ANXA2), and others—exhibited pronounced differences in proteoform patterns between nonmalignant and malignant tissues. Conclusions: Most proteoform patterns of the same protein were highly similar, with the dominant peak corresponding to theoretical (unmodified) protein parameters. However, certain proteins displayed altered proteoform patterns and additional proteoforms in cancer compared to controls. These proteins were prioritized for further characterization.
- Open Access
- 8 May 2025
- Published by MDPI AG in Preprints.org
Proteoform Patterns in the Samples of Hepatocellular Carcinoma: Aspects of Oncomarkers
This study aimed to generate comparative proteomics data, including various proteoforms, in hepatocellular carcinoma (HCC) and nonmalignant liver tissues. Using a panoramic, integrative top-down proteomics approach—sectional two-dimensional gel electrophoresis (2DE) coupled with liquid chromatography-electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS)—we obtained and visualized over 2,500 proteoform patterns for each sample type. This allowed us to identify specific protein signatures and common patterns distinguishing nonmalignant and malignant human liver cells. The results demonstrated that most proteoform patterns were highly similar, with the dominant peak matching the theoretical (unmodified) protein parameters. From these, 1,270 reproducibly detected protein patterns were selected for further analysis. Additionally, 38 proteins—including pyruvate kinase PKM (KPYM), annexin A2 (ANXA2), and others—showed pronounced differences in proteoform patterns between nonmalignant and malignant tissues and were prioritized for subsequent proteoform characterization.
- 8 May 2025
- Published by MDPI AG in Preprints.org
Open AccessProteoform Patterns in the Samples of Hepatocellular Carcinoma: Aspects of Oncomarkers
This study aimed to generate comparative proteomics data, including various proteoforms, in hepatocellular carcinoma (HCC) and nonmalignant liver tissues. Using a panoramic, integrative top-down proteomics approach—sectional two-dimensional gel electrophoresis (2DE) coupled with liquid chromatography-electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS)—we obtained and visualized over 2,500 proteoform patterns for each sample type. This allowed us to identify specific protein signatures and common patterns distinguishing nonmalignant and malignant human liver cells. The results demonstrated that most proteoform patterns were highly similar, with the dominant peak matching the theoretical (unmodified) protein parameters. From these, 1,270 reproducibly detected protein patterns were selected for further analysis. Additionally, 38 proteins—including pyruvate kinase PKM (KPYM), annexin A2 (ANXA2), and others—showed pronounced differences in proteoform patterns between nonmalignant and malignant tissues and were prioritized for subsequent proteoform characterization.
- Open Access
- 18 June 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (12) , 6533
Evaluation of Haptoglobin and Its Proteoforms as Glioblastoma Markers
Haptoglobin (Hp) is a blood plasma glycoprotein that plays a critical role in tissue protection and the prevention of oxidative damage. Haptoglobin is an acute-phase protein, its concentration in plasma changes in pathology, and the test for its concentration is part of normal clinical practice. Haptoglobin is a conservative protein and is the subject of research as a potential biomarker of many diseases, including malignant neoplasms. The Human Hp gene is polymorphic and controls the synthesis of three major phenotypes—homozygous Hp1-1 and Hp2-2, and heterozygous Hp2-1, determined by a combination of allelic variants that are inherited. Numerous studies indicate that the phenotype of haptoglobin can be used to judge the individual’s predisposition to various diseases. In addition, Hp undergoes various post-translational modifications (PTMs). Glioblastoma multiform (GBM) is the most malignant primary brain tumor. In our study, we have analyzed the state of Hp proteoforms in plasma and cells using 1D (SDS-PAGE) and 2D electrophoresis (2DE) with the following mass spectrometry (LC ES-MS/MS) or Western blotting. We found that the levels of α2- and β-chain proteoforms are up-regulated in the plasma of GBM patients. An unprocessed form of Hp2-2 (PreHp2-2, zonulin) with unusual biophysical parameters (pI/Mw) was also detected in the plasma of GBM patients and glioblastoma cells. Altogether, this data shows the possibility to use proteoforms of haptoglobin as a potential GBM-specific plasma biomarker.
- 18 June 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (12) , 6533
Open AccessEvaluation of Haptoglobin and Its Proteoforms as Glioblastoma Markers
Haptoglobin (Hp) is a blood plasma glycoprotein that plays a critical role in tissue protection and the prevention of oxidative damage. Haptoglobin is an acute-phase protein, its concentration in plasma changes in pathology, and the test for its concentration is part of normal clinical practice. Haptoglobin is a conservative protein and is the subject of research as a potential biomarker of many diseases, including malignant neoplasms. The Human Hp gene is polymorphic and controls the synthesis of three major phenotypes—homozygous Hp1-1 and Hp2-2, and heterozygous Hp2-1, determined by a combination of allelic variants that are inherited. Numerous studies indicate that the phenotype of haptoglobin can be used to judge the individual’s predisposition to various diseases. In addition, Hp undergoes various post-translational modifications (PTMs). Glioblastoma multiform (GBM) is the most malignant primary brain tumor. In our study, we have analyzed the state of Hp proteoforms in plasma and cells using 1D (SDS-PAGE) and 2D electrophoresis (2DE) with the following mass spectrometry (LC ES-MS/MS) or Western blotting. We found that the levels of α2- and β-chain proteoforms are up-regulated in the plasma of GBM patients. An unprocessed form of Hp2-2 (PreHp2-2, zonulin) with unusual biophysical parameters (pI/Mw) was also detected in the plasma of GBM patients and glioblastoma cells. Altogether, this data shows the possibility to use proteoforms of haptoglobin as a potential GBM-specific plasma biomarker.
- Open Access
- 4 July 2019
- Published by MDPI AG in Preprints.org
2DE-pattern: A Database for Inventory of Human Proteoforms
The human proteome is composed from diverse and heterogeneous gene products/proteoforms. Previously, we have been discussing the main technical aspects in developing for inventory of human proteoforms that would be visually attractive, clear, and easy to search (Naryzhny S. J. Proteomics 2018, S1874-3919(18) 30220-3). Here, we present our first draft of the database of proteoforms that is based on this discussion. The database principles and structure are described. The database is called “2DE-pattern” as it contains multiple isoform-centric patterns of proteoforms separated according to 2DE principles.
- 4 July 2019
- Published by MDPI AG in Preprints.org
Open Access2DE-pattern: A Database for Inventory of Human Proteoforms
The human proteome is composed from diverse and heterogeneous gene products/proteoforms. Previously, we have been discussing the main technical aspects in developing for inventory of human proteoforms that would be visually attractive, clear, and easy to search (Naryzhny S. J. Proteomics 2018, S1874-3919(18) 30220-3). Here, we present our first draft of the database of proteoforms that is based on this discussion. The database principles and structure are described. The database is called “2DE-pattern” as it contains multiple isoform-centric patterns of proteoforms separated according to 2DE principles.